Thomas F. Miller
CIK: 0002034921
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Miller Thomas F.
Miller Thomas F. (SEC CIK 0002034921) files insider reports with the SEC as Chief Executive Officer of Iambic Therapeutics, Inc. (IAM) and Director of VERACYTE, INC. (VCYT).
Signal8 holds 6 ownership filings by Miller Thomas F. (2 Form 3, 4 Form 4), filed between Sep 4, 2024 and Oct 16, 2026. Those filings report 4 transactions, from Sep 3, 2024 to Oct 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Miller Thomas F.'s filings is in SAN DIEGO, CA.
Recent filings by Miller Thomas F.
Other insiders filing for Iambic Therapeutics, Inc. (IAM)
- Catalio Capital Management, LP, 10% Owner
- Vogelstein R Jacob, Director
- Secora Michael, CFO & Chief Corp Dev Ofcr
- RASTETTER WILLIAM H, Director
- Rachlin Evan Lockwood, Director
- EMSTER KURT VON, Director